DOI QR코드

DOI QR Code

Positive Predictive Values of Abnormality Scores From a Commercial Artificial Intelligence-Based Computer-Aided Diagnosis for Mammography

  • Si Eun Lee (Department of Radiology, Yongin Severance Hospital, Yonsei University College of Medicine) ;
  • Hanpyo Hong (Department of Radiology, Yongin Severance Hospital, Yonsei University College of Medicine) ;
  • Eun-Kyung Kim (Department of Radiology, Yongin Severance Hospital, Yonsei University College of Medicine)
  • Received : 2023.07.24
  • Accepted : 2023.12.05
  • Published : 2024.04.01

Abstract

Objective: Artificial intelligence-based computer-aided diagnosis (AI-CAD) is increasingly used in mammography. While the continuous scores of AI-CAD have been related to malignancy risk, the understanding of how to interpret and apply these scores remains limited. We investigated the positive predictive values (PPVs) of the abnormality scores generated by a deep learning-based commercial AI-CAD system and analyzed them in relation to clinical and radiological findings. Materials and Methods: From March 2020 to May 2022, 656 breasts from 599 women (mean age 52.6 ± 11.5 years, including 0.6% [4/599] high-risk women) who underwent mammography and received positive AI-CAD results (Lunit Insight MMG, abnormality score ≥ 10) were retrospectively included in this study. Univariable and multivariable analyses were performed to evaluate the associations between the AI-CAD abnormality scores and clinical and radiological factors. The breasts were subdivided according to the abnormality scores into groups 1 (10-49), 2 (50-69), 3 (70-89), and 4 (90-100) using the optimal binning method. The PPVs were calculated for all breasts and subgroups. Results: Diagnostic indications and positive imaging findings by radiologists were associated with higher abnormality scores in the multivariable regression analysis. The overall PPV of AI-CAD was 32.5% (213/656) for all breasts, including 213 breast cancers, 129 breasts with benign biopsy results, and 314 breasts with benign outcomes in the follow-up or diagnostic studies. In the screening mammography subgroup, the PPVs were 18.6% (58/312) overall and 5.1% (12/235), 29.0% (9/31), 57.9% (11/19), and 96.3% (26/27) for score groups 1, 2, 3, and 4, respectively. The PPVs were significantly higher in women with diagnostic indications (45.1% [155/344]), palpability (51.9% [149/287]), fatty breasts (61.2% [60/98]), and certain imaging findings (masses with or without calcifications and distortion). Conclusion: PPV increased with increasing AI-CAD abnormality scores. The PPVs of AI-CAD satisfied the acceptable PPV range according to Breast Imaging-Reporting and Data System for screening mammography and were higher for diagnostic mammography.

Keywords

Acknowledgement

This work was supported by Medical AI Clinic Program through the National IT Industry Promotion Agency (NIPA), funded by the Ministry of Science and ICT (MSIT).

References

  1. Salim M, Dembrower K, Eklund M, Lindholm P, Strand F. Range of radiologist performance in a population-based screening cohort of 1 million digital mammography examinations. Radiology 2020;297:33-39  https://doi.org/10.1148/radiol.2020192212
  2. Checka CM, Chun JE, Schnabel FR, Lee J, Toth H. The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 2012;198:W292-W295  https://doi.org/10.2214/AJR.10.6049
  3. Yoon JH, Strand F, Baltzer PAT, Conant EF, Gilbert FJ, Lehman CD, et al. Standalone AI for breast cancer detection at screening digital mammography and digital breast tomosynthesis: a systematic review and meta-analysis. Radiology 2023;307:e222639 
  4. McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, et al. International evaluation of an AI system for breast cancer screening. Nature 2020;577:89-94  https://doi.org/10.1038/s41586-019-1799-6
  5. Schaffter T, Buist DSM, Lee CI, Nikulin Y, Ribli D, Guan Y, et al. Evaluation of combined artificial intelligence and radiologist assessment to interpret screening mammograms. JAMA Netw Open 2020;3:e200265 
  6. Lee JH, Kim KH, Lee EH, Ahn JS, Ryu JK, Park YM, et al. Improving the performance of radiologists using artificial intelligence-based detection support software for mammography: a multi-reader study. Korean J Radiol 2022;23:505-516  https://doi.org/10.3348/kjr.2021.0476
  7. Kim HE, Kim HH, Han BK, Kim KH, Han K, Nam H, et al. Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study. Lancet Digit Health 2020;2:e138-e148  https://doi.org/10.1016/S2589-7500(20)30003-0
  8. Gao Y, Geras KJ, Lewin AA, Moy L. New frontiers: an update on computer-aided diagnosis for breast imaging in the age of artificial intelligence. AJR Am J Roentgenol 2019;212:300-307  https://doi.org/10.2214/AJR.18.20392
  9. Erickson BJ, Korfiatis P, Kline TL, Akkus Z, Philbrick K, Weston AD. Deep learning in radiology: does one size fit all? J Am Coll Radiol 2018;15(3 Pt B):521-526  https://doi.org/10.1016/j.jacr.2017.12.027
  10. Yoon JH, Kim EK. Deep learning-based artificial intelligence for mammography. Korean J Radiol 2021;22:1225-1239  https://doi.org/10.3348/kjr.2020.1210
  11. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-1399  https://doi.org/10.1016/S0140-6736(01)06524-2
  12. Kim EK, Kim HE, Han K, Kang BJ, Sohn YM, Woo OH, et al. Applying data-driven imaging biomarker in mammography for breast cancer screening: preliminary study. Sci Rep 2018;8:2762 
  13. Salim M, Wahlin E, Dembrower K, Azavedo E, Foukakis T, Liu Y, et al. External evaluation of 3 commercial artificial intelligence algorithms for independent assessment of screening mammograms. JAMA Oncol 2020;6:1581-1588  https://doi.org/10.1001/jamaoncol.2020.3321
  14. Lee SE, Han K, Yoon JH, Youk JH, Kim EK. Depiction of breast cancers on digital mammograms by artificial intelligence-based computer-assisted diagnosis according to cancer characteristics. Eur Radiol 2022;32:7400-7408  https://doi.org/10.1007/s00330-022-08718-2
  15. D'Orsi CJ, Sickles EA, Mendelson EB, Morris EA. ACR BI-RADS atlas: breast imaging reporting and data system. Reston, VA: American College of Radiology, 2013 
  16. Hickman SE, Woitek R, Le EPV, Im YR, Mouritsen Luxhoj C, Aviles-Rivero AI, et al. Machine learning for workflow applications in screening mammography: systematic review and meta-analysis. Radiology 2022;302:88-104 https://doi.org/10.1148/radiol.2021210391